BCG Ag85A peptides
Pre-clinical- Indications
- Melanoma
Company intelligence / Profile preview
Sanroad Biological Products
Beijing, Beijing, Chinapmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
The company specializes in biopharmaceutical products including diagnostic solutions for tuberculosis, vaccines for meningococcal disease, and cell-mediated immunity assay kits[1].
- Therapeutic areas
- Infectious Diseases
- Modalities
- BiopharmaceuticalsVaccinesDiagnostic products
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Relationship with Simcere Pharmaceutical Group Limited[3][5]
Beyond the preview
Go deeper on Sanroad Biological Products.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sanroad Biological Products.